These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20599554)

  • 1. Production and characterization of agonistic monoclonal antibodies against chicken CD40.
    Chen CH; Abi-Ghanem D; Njongmeta L; Bray J; Mwangi W; Waghela SD; McReynolds JL; Ing NH; Berghman LR
    Dev Comp Immunol; 2010 Nov; 34(11):1139-43. PubMed ID: 20599554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of chickens with an agonistic monoclonal anti-chicken CD40 antibody-hapten complex: rapid and robust IgG response induced by a single subcutaneous injection.
    Chen CH; Abi-Ghanem D; Waghela SD; Chou WK; Farnell MB; Mwangi W; Berghman LR
    J Immunol Methods; 2012 Apr; 378(1-2):116-20. PubMed ID: 22366632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
    Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
    J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
    J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand supports the long-term maintenance and differentiation of chicken B cells in culture.
    Kothlow S; Morgenroth I; Tregaskes CA; Kaspers B; Young JR
    Dev Comp Immunol; 2008; 32(9):1015-26. PubMed ID: 18374414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-CD40 ligand interactions stimulate B cell antigen processing.
    Faassen AE; Dalke DP; Berton MT; Warren WD; Pierce SK
    Eur J Immunol; 1995 Dec; 25(12):3249-55. PubMed ID: 8566008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.
    Néron S; Nadeau PJ; Darveau A; Leblanc JF
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):25-40. PubMed ID: 21234809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
    Peterson KE; Braley-Mullen H
    J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
    Shepherd DM; Kerkvliet NI
    J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
    Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
    J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
    Müerköster S; Laman JD; Rocha M; Umansky V; Schirrmacher V
    Clin Cancer Res; 2000 May; 6(5):1988-96. PubMed ID: 10815924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo.
    Stax AM; Gelderman KA; Kamerling SW; van der Geest R; Schlagwein N; van Kooten C
    J Immunol Methods; 2008 Jun; 335(1-2):46-52. PubMed ID: 18384807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14.
    Francisco JA; Donaldson KL; Chace D; Siegall CB; Wahl AF
    Cancer Res; 2000 Jun; 60(12):3225-31. PubMed ID: 10866315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.
    Johnson-Léger C; Hasbold J; Holman M; Klaus GG
    J Immunol; 1997 Aug; 159(3):1150-9. PubMed ID: 9233608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.